Net Loss Per Share	9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	10. Net Loss Per Share The Company reports two separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the period by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. The common stock equivalents include all common stock issuable upon exercise of outstanding warrants, options and vesting of restricted stock awards. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the three months ended September 30, 2023, and 2022 totaled 2,465 and 950 thousand shares, respectively. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the nine months ended September 30, 2023, and 2022 totaled 2,341 and 1,274 thousand shares, respectively. Since the Company is in a net loss position for the three and nine months ended September 30, 2023, and 2022, basic and dilutive net loss per share is the same.

Net Loss Per Share

9 Months Ended

Sep. 30, 2023

10. Net Loss Per Share

The Company reports two separate net loss per share numbers, basic and diluted. Basic net loss attributable to common stockholders per share is computed by dividing net loss attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders for the period by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. The common stock equivalents include all common stock issuable upon exercise of outstanding warrants, options and vesting of restricted stock awards. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the three months ended September 30, 2023, and 2022 totaled 2,465 and 950 thousand shares, respectively. The aggregate number of common stock equivalents excluded from the diluted loss per share calculation for the nine months ended September 30, 2023, and 2022 totaled 2,341 and 1,274 thousand shares, respectively. Since the Company is in a net loss position for the three and nine months ended September 30, 2023, and 2022, basic and dilutive net loss per share is the same.